Subscribe

What are you looking for?

Main Menu

明報新聞網

石四藥集團來特莫韋注射液獲生產注冊

Future Wealths
Future Wealths
10 9 月, 2026
One Min Read
1 Views
0 Comments
石四藥集團（2005）集團公布，集團已取得國家藥監局有關來特莫韋注射液(12ml:240mg)的藥品生產註冊批件，屬於化學藥品第4類，視同通過一致性評價。

原文: https://finance.mingpao.com/fin/instantf/20260910/1789024524493/%E7%9F%B3%E5%9B%9B%E8%97%A5%E9%9B%86%E5%9C%98%E4%BE%86%E7%89%B9%E8%8E%AB%E9%9F%8B%E6%B3%A8%E5%B0%84%E6%B6%B2%E7%8D%B2%E7%94%9F%E7%94%A2%E6%B3%A8%E5%86%8A%22%20target=%22blank

Last Update: 10 9 月, 2026

Please share this article if you like it!

Link Copied!
Future Wealths
Written By

Future Wealths

Other Articles

Related Posts

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept